What Every Lab Needs to Know about the Medicare Part B Clinical Laboratory Price Cuts That Take Effect in Just 157 Days, on Jan. 1, 2018

Another big question is whether the lobbying of medical laboratory and pathology societies can educate and convince members of Congress to delay and reform the PAMA Final Rule that uses the market price study of what private payers pay for lab tests Coming in just five months are the deepest, most painful clinical laboratory test price cuts ever implemented by Medicare officials. During calendar 2018 alone, both the Centers for Medicare and Medicaid Services (CMS) and the Office of Inspector...

Biggest Opportunity for Clinical Laboratory Industry is Utilization Management of Lab Tests, But Only If It Is Done Well

Effective medical lab/physician collaborations to improve how lab tests are ordered and used can deliver big improvements in patient outcomes while reducing healthcare costs Utilization management of clinical laboratory tests may be the single hottest trend in laboratory medicine today. Across the nation, medical laboratory scientists and pathologists are getting out of the lab to collaborate with physicians to meet the common goal of ordering the right test for the right patient at the right...

Big Crowd of Pathologists and Clinical Laboratory Leaders Converges on New Orleans to Learn about Healthcare Trends, New Medical Laboratory Technologies

Speakers during the opening session discussed the major changes happening in healthcare today, along with insights about the new ‘Clinical Lab 2.0’ concept DATELINE—NEW ORLEANS: This was a week of revelations and strategic insight for more than 900 clinical laboratory administrators, pathologists, and medical laboratory suppliers now attending the 22nd annual Executive War College on Lab and Pathology Management. From the opening keynote presentations to the lab management case studies that...

National Clinical Lab Sales Excellence Award Winner in Seattle Leverages Cooperation between Sales and Operations to Win New Clients, Revenue

PACLAB’s effective use of clinical laboratory sales reps demonstrates how effective collaboration between sales and operations can help an outreach lab increase specimen volume and expand its market share Despite falling prices for clinical laboratory testing and payers increasingly excluding labs from their provide networks, savvy hospitals and health systems continue to enjoy profitable laboratory outreach programs. One common factor shared by these successful hospital lab outreach...

Diagnostics Marketing Association’s (DxMA’s) Global Marketing Summit Will Convene in New Orleans Just Prior to the Executive War College (EWC) to Discuss Primary Trends Facing IVD Manufacturers, Clinical Laboratories

The DxMA Summit’s agenda will complement EWC’s and will explore disruptive technologies likely to be of great interest to medical laboratory leaders and pathology groups Cybersecurity, wearable technology, and social media are the primary trends facing in vitro diagnostics (IVD) manufacturers and clinical laboratories. That’s according to Debra Harrsch, President-elect of the Diagnostics Marketing Association (DxMA), a self-funded organization devoted to helping diagnostic marketing...